Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 2005 May;49(5):2102–2105. doi: 10.1128/AAC.49.5.2102-2105.2005

Origin and Dissemination of Chloroquine-Resistant Plasmodium falciparum with Mutant pfcrt Alleles in the Philippines

Nanhua Chen 1, Danny W Wilson 2,, Cielo Pasay 3,, David Bell 2,§, Laura B Martin 2,, Dennis Kyle 1,4, Qin Cheng 1,*
PMCID: PMC1087682  PMID: 15855538

Abstract

The pfcrt allelic type and adjacent microsatellite marker type were determined for 82 Plasmodium falciparum isolates from the Philippines. Mutant pfcrt allelic types P1a and P2a/P2b were dominant in different locations. Microsatellite analysis revealed that P2a/P2b evolved independently in the Philippines, while P1a shared common ancestry with Papua New Guinea chloroquine-resistant parasites.


Mutations in the pfcrt gene have been associated with chloroquine resistance in Plasmodium falciparum (4, 6, 8, 12). Fifteen amino acid mutations at positions 72, 74, 75, 76, 97, 144, 148, 160, 194, 220, 271, 326, 333, 356, and 371 have been identified in pfcrt of chloroquine-resistant (CQR) parasites from various regions (3, 7-9, 15). In general, the CQR isolates from Southeast Asia and Africa have pfcrt alleles with seven to nine mutated codons that are linked to a pattern of C/I/E/T/H(L)/A(F)/L(I)/L/I(T)/S/E/S/T(S)/T/I (boldface italics indicate the mutated codons), from positions 72 to 371, while the CQR parasites from South America and Papua New Guinea (PNG) possess pfcrt alleles with four or five mutated codons forming a pattern of S(C)/M/N/T/H/A/L/L/I/S/Q/D/T/L/R (3, 4, 8, 9, 15). Our previous study identified novel pfcrt allelic types in parasites from Morong, the Philippines, with four or five mutated amino acids linked into a pattern of S(C)/M/N/T/H/T/L/Y/I/A/Q/D/T/I/R. In vitro chloroquine susceptibility testing indicated that these parasites with the novel pfcrt allelic types were CQR (3). Among the mutated codons, A144T and L160Y were exclusively identified in the Philippine isolates, suggesting that CQR pfcrt alleles evolved independently in the Philippines (3). The novel Philippine pfcrt allelic types were named P2a and P2b according to the nomenclature used by Wellems and Plowe (3, 14).

In this study, we analyzed pfcrt allelic types in P. falciparum isolates from several locations within the Philippines to ascertain the geographical distribution of these novel and other pfcrt allelic types. The ancestral origin of the observed CQR pfcrt allelic types was investigated by microsatellite marker analysis (15).

Eighty-two P. falciparum isolates were collected from the following locations in the Philippines between 1989 and 2002 (Fig. 1): Morong (n = 20) (3), Bagac (n = 4), and Dinalupiham (n = 12) in Bataan Province, Central Luzon; Puerto Princesa, Palawan (n = 12), and Tayabas (n = 6) in Quezon Province, South Luzon; Conner (n = 10) and Kabugao (n = 5) in Kalinga-Apayao Province, Northern Luzon; and Agusan del Sur, Mindanao (n = 13). Genomic DNA was extracted using a Wizard Plus Minipreps DNA Purification System (Promega), and DNA fragments covering the 12 known mutations in pfcrt were amplified by PCR (3). PCR products were purified with a NucleoSpin extraction kit (Macherey-Nagel) and sequenced. Microsatellite markers flanking the pfcrt gene, B5M77(−20 kb), 2E10 (−5 kb), PE12A (+6 kb), 2H4 (+22 kb), and PE14F (+106 kb), were amplified and analyzed as previously described (15).

FIG. 1.

FIG. 1.

Locations in the Philippines where parasite isolates were examined for pfcrt allelic types and microsatellite marker types. Numbers in parentheses following the name of a district/municipality indicate the total number of parasite samples. pfcrt allelic types and numbers detected at each location are indicated below the name of each district/municipality.

Polymorphisms in pfcrt in P. falciparum collected from the Philippines are shown in Table 1. Novel pfcrt allelic types P2a and P2b with mutations at A144T and L160Y were identified in 18/20 and 1/20 Morong isolates (Central Luzon) (3), respectively. P2a was also the major pfcrt allelic type in Bagac (4/4) and Dinalupiham (11/12) in Central Luzon, while P2b was the major type in Puerto Princesa, Palawan (9/12). In comparison, P2b was only identified in a small proportion of the isolates from Tayabas (2/6) in Southern Tagalog and from Agusan del Sur, Mindanao (2/13). Neither P2a nor P2b was detected in isolates from Conner and Kabugao, Northern Luzon, where P1a, the PNG allelic type, dominated. The chloroquine-sensitive wild-type pfcrt was detected in one isolate from Tayabas. Overall, among the 82 Philippine isolates analyzed, 48 (58.5%) possessed the P2a/P2b alleles, 32 (39%) had the P1a allele, and 1 (1.2%) each had the E1a allele and the wild type.

TABLE 1.

pfcrt allelic types and polymorphisms in microsatellite markers flanking pfcrt in P. falciparum samples collected from different districts/municipalities in the Philippines compared to those from other areas

Origin (total no. of isolates) and sample No. of isolates % MSb marker size (bp)
PFCRT (allelic type)a MS marker size (bp)
B5M77 (−20 kb) 2F10 (−5 kb) PE12A (+6 kb) 2H4 (+22 kb) PE14F (+106 kb)
Philippines
    Morong (20)
        PH1 group 18 90 149 182 CMNTHTYAQDLR (P2a) 314 228 136
        PH2 1 5 149 182 SMNTHTYAQDIR (P2b) 314 228 136
        PH4 1 5 149 170 CIETHALSESTI (E1a) 314 204 145
    Bagac (4), B1 group 4 100 149 182 CMNTHTYAQDLR (P2a) 314 228 136
    Dinalupiham (12)
        D1 group 10 83 149 182 CMNTHTYAQDLR (P2a) 314 228 136
        D16 1 8 149 182 CMNTHTYAQDLR (P2a) 314 220 142
        D3 1 8 149 182 SMNTHTYAQDIR (P2b) 314 228 136
    Palawan (12)
        PAL2 group 5 42 149 182 SMNTHTYAQDIR (P2b) 314 228 136
        PAL12 group 2 17 149 182 SMNTHTYAQDIR (P2b) 314 228 151
        PAL7 1 8 149 182 SMNTHTYAQDIR (P2b) 314 228 148
        PAL6 1 8 149 182 SMNTHTYAQDIR (P2b) 314 220 136
        PAL5 group 2 17 147 194 SMNTHALSQDLR (P1a) 328 228 136
        PAL1 1 8 147 194 SMNTHALSQDLR (P1a) 328 228 148
    Tayabas (6)
        T1 group 2 33 149 174 SMNTHALSQDLR (P1a) 328 218 148
        T4 1 17 149 174 SMNTHALSQDLR (P1a) 328 184 148
        T2 group 2 33 149 182 SMNTHTYAQDIR (P2b) 314 228 136
        T3 1 17 149 176 CMNKHALAQNIR (CQS) 328 182 142
    Mindanao (13)
        L104 group 4 31 149 174 SMNTHALSQDLR (P1a) 328 184 148
        L088 group 2 15 149 174 SMNTHALSQDLR (P1a) 328 184 151
        L016 1 8 149 174 SMNTHALSQDLR (P1a) 328 184 142
        M013 group 2 15 149 174 SMNTHALSQDLR (P1a) 328 206 148
        M007 1 8 149 174 SMNTHALSQDLR (P1a) 328 186 148
        X039 1 8 149 174 SMNTHALSQDLR (P1a) 328 204 148
        X098 1 8 149 182 SMNTHTYAQDIR (P2b) 314 202 148
        X097 1 8 149 182 SMNTHTYAQDIR (P2b) 314 202 151
    Connor (10)
        C3 group 7 70 149 174 SMNTHALSQDLR (P1a) 328 184 148
        C1 group 3 30 149 174 SMNTHALSQDLR (P1a) 328 228 136
    Kabugao (5), Kab1 group 5 100 149 174 SMNTHALSQDLR (P1a) 328 184 148
Other areas
    Brazil (1), 7G8 1 151 190 SMNTHALSQDLR (W1a) 314 194 142
    Thailand (5)
        Dd2 group 2 149 170 CIETHALSESTI (E1a) 314 204 145
        K1 1 149 170 CIETHALSESII (E1b) 314 204 145
        TM93-C1088 1 149 170 CIETLALSESTI (E1c) 314 204 145
        C2B 1 149 170 CIETHALSESTI (E1a) 314 184 148
    Solomon (4)
        N18 group 2 149 174 SMNTHALSQDLR (P1a) 328 184 142
        N70 group 2 147 174 SMNTHALSQDLR (P1a) 328 184 142
    PNG (6)
        AN001 group 4 149 174 SMNTHALSQDLR (P1a) 328 184 142
        AN018 group 2 149 174 SMNTHALSQDLR (P1a) 328 192 139
a

Amino acid positions in PFCRT shown are 72, 74, 75, 76, 97, 144, 160, 220, 271, 326, 356, and 371. pfcrt allelic types E, W, and P refer to resistant loci originating in the eastern and western hemispheres and in the Pacific, respectively (3, 14).

b

MS, microsatellite.

Genotyping using msp1, msp2, and glurp (10) was performed to examine the heterogeneity of the isolates on loci not linked with pfcrt. Various banding patterns were observed among isolates with identical novel P2a and P2b pfcrt allelic types, indicating the isolates were diverse rather than clonal (data not shown). This is highlighted in 18 Morong isolates, where nine distinct banding patterns identified for msp1, msp2, and glurp corresponded to the P2a pfcrt allele.

The dissemination of mutant pfcrt allelic types in the Philippines is shown in Fig. 1. P2a was the major type in isolates from Central Luzon, while P2b predominated in those from Palawan. P1a was found to be dominant in isolates from Northern Luzon and Mindanao. Although geographically the provinces of Bataan and Quezon are situated in Luzon, they are well separated by mountain ranges. This may provide an explanation for the dominance of P2a and P1a, respectively, in these provinces. Palawan, though separated by sea, shares a closely related dominant pfcrt allelic type with Central Luzon. The novel mutations in P2a and P2b alleles (A144T and L160Y) were not found in a wild-type pfcrt gene, indicating that these mutations in the CQR isolates were not inherited from chloroquine-susceptible parasites in the Philippines. In addition, none of the Philippine isolates with A144T and L160Y mutations (n = 48) carried the A220S mutation very commonly seen in CQR parasites elsewhere. The mutually exclusive presence of A144T/L160Y with A220S suggests that A144T and L160Y may play a similar role as A220S in CQR.

Five microsatellite markers flanking the pfcrt gene, B5M77, 2E10, PE12A, 2H4, and PE14F (15), were analyzed for all the Philippine isolates included in this study, as well as several standard laboratory lines and isolates from Southeast Asia, Oceania, and South America. As shown in Table 1, all isolates with the P2a pfcrt allele, except for one from Dinalupiham (D16), gave the identical size for all five microsatellite markers, and the banding pattern was unique compared to that in parasites from other regions. While some isolates with the P2b pfcrt allele had microsatellite markers identical to those in P2a, others showed variations in some microsatellite markers. The unique microsatellite marker patterns of P2a/P2b pfcrt allelic types demonstrate that P2a/P2b alleles evolved independently in the Philippines. The similarity between the microsatellite patterns of P2a and P2b and fact that P2b carried an extra mutation (C72S) suggest that the P2b allelic type was derived from P2a. We hypothesize that CQR parasites (P2a) originated in Central Luzon and spread south to Palawan and Mindanao with the addition of an extra mutation in pfcrt (P2b). This is consistent with field observation of chloroquine resistance in Philippines: first documented in Luzon from the early 1970s to the 1980s (2, 5, 11, 13) and subsequently in Palawan (1).

In contrast, the microsatellite marker patterns of the Philippine isolates with P1a pfcrt type closely resembled that of the PNG and the Solomon Islands isolates, suggesting that P1a pfcrt alleles in parasites from the Philippines and Oceania evolved from a common origin and may have spread from neighboring countries. The only Philippine isolate with the E1a pfcrt type (PH4) was identical to Dd2 (Thailand) in microsatellite marker pattern (Table 1). Significantly, this was obtained in close proximity to the site of the main transit camp for Indochinese refugees in the Philippines.

This study confirms that at least two founder events of chloroquine resistance have occurred in the Pacific region, one in PNG and one in the Philippines, and demonstrates that under chloroquine selection pressure, P. falciparum parasites with various genetic backgrounds have developed chloroquine resistance independently by mutating different positions in the pfcrt gene.

Acknowledgments

This research was funded in part by the U.S. Army Medical Research and Materiel Command, Ft. Detrick, MD, and an NIH grant (2RO1 AI047500) and by the National Health and Medical Research Council, Australia, and assisted by AusAID through the Research Institute for Tropical Medicine, Philippines.

The opinions expressed herein are those of the authors and do not necessarily reflect those of the Defence Health Service or any extant policy of the Department of Defence, Australia or United States.

We thank Rouel Go and colleagues from the Malaria Study Group, the Research Institute for Tropical Medicine, Manila, Philippines, for collecting malaria-infected samples in the Philippines.

REFERENCES

  • 1.Baird, J. K., M. E. Caneta, S. Masbar, D. G. Bustos, J. A. Abrenica, A. V. Layawen, J. M. Calulut, B. Leksana, and F. S. Wignall. 1996. Survey of resistance to chloroquine of falciparum and vivax malaria in Palawan, The Philippines. Trans. R. Soc. Trop. Med. Hyg. 90:413-414. [DOI] [PubMed] [Google Scholar]
  • 2.Buck, R. L., A. K. Alcantara, C. V. Uylangco, and J. H. Cross. 1983. Malaria at San Lazaro Hospital, Manila, Philippines, 1979-1981. Am. J. Trop. Med. Hyg. 32:212-216. [DOI] [PubMed] [Google Scholar]
  • 3.Chen, N., D. E. Kyle, C. Pasay, E. V. Fowler, J. Baker, J. M. Peters, and Q. Cheng. 2003. pfcrt allelic types with two novel amino acid mutations in chloroquine-resistant Plasmodium falciparum isolates from the Philippines. Antimicrob. Agents Chemother. 47:3500-3505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Chen, N., B. Russell, J. Staley, B. Kotecka, P. Nasveld, and Q. Cheng. 2001. Sequence polymorphisms in pfcrt are strongly associated with chloroquine resistance in Plasmodium falciparum. J. Infect. Dis. 183:1543-1545. [DOI] [PubMed] [Google Scholar]
  • 5.Clyde, D. F., G. T. Shute, V. C. McCarthy, and R. P. Sangalang. 1971. Characterization of a drug resistant strain of Plasmodium falciparum from the Philippines. J. Trop. Med. Hyg. 74:101-105. [PubMed] [Google Scholar]
  • 6.Djimde, A., O. K. Doumbo, J. F. Cortese, K. Kayentao, S. Doumbo, Y. Diourte, A. Dicko, X. Z. Su, T. Nomura, D. A. Fidock, T. E. Wellems, C. V. Plowe, and D. Coulibaly. 2001. A molecular marker for chloroquine-resistant falciparum malaria. N. Engl. J. Med. 344:257-263. [DOI] [PubMed] [Google Scholar]
  • 7.Durrand, V., A. Berry, R. Sem, P. Glaziou, J. Beaudou, and T. Fandeur. 2004. Variations in the sequence and expression of the Plasmodium falciparum chloroquine resistance transporter (Pfcrt) and their relationship to chloroquine resistance in vitro. Mol. Biochem. Parasitol. 136:273-285. [DOI] [PubMed] [Google Scholar]
  • 8.Fidock, D. A., T. Nomura, A. K. Talley, R. A. Cooper, S. M. Dzekunov, M. T. Ferdig, L. M. Ursos, A. B. Sidhu, B. Naude, K. W. Deitsch, X. Z. Su, J. C. Wootton, P. D. Roepe, and T. E. Wellems. 2000. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell 6:861-871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Mehlotra, R. K., H. Fujioka, P. D. Roepe, O. Janneh, L. M. Ursos, V. Jacobs-Lorena, D. T. McNamara, M. J. Bockarie, J. W. Kazura, D. E. Kyle, D. A. Fidock, and P. A. Zimmerman. 2001. Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America. Proc. Natl. Acad. Sci. USA 98:12689-12694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Ranford-Cartwright, L. C., J. Taylor, T. Umasunthar, L. H. Taylor, H. A. Babiker, B. Lell, J. R. Schmidt-Ott, L. G. Lehman, D. Walliker, and P. G. Kremsner. 1997. Molecular analysis of recrudescent parasites in a Plasmodium falciparum drug efficacy trial in Gabon. Trans. R. Soc. Trop. Med. Hyg. 91:719-724. [DOI] [PubMed] [Google Scholar]
  • 11.Shute, G. T., A. P. Ray, and R. Sangalang. 1972. Preliminary studies on a Philippine strain of Plasmodium falciparum resistant to amodiaquine. J. Trop. Med. Hyg. 75:125-132. [PubMed] [Google Scholar]
  • 12.Sidhu, A. B., D. Verdier-Pinard, and D. A. Fidock. 2002. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 298:210-213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Valera, C. V., and G. T. Shute. 1976. Preliminary studies on the response of Plasmodium falciparum to chloroquine in the Philippines, with the in vitro technique. Bull. W. H. O. 53:391-398. [PMC free article] [PubMed] [Google Scholar]
  • 14.Wellems, T. E., and C. V. Plowe. 2001. Chloroquine-resistant malaria. J. Infect. Dis. 184:770-776. [DOI] [PubMed] [Google Scholar]
  • 15.Wootton, J. C., X. Feng, M. T. Ferdig, R. A. Cooper, J. Mu, D. I. Baruch, A. J. Magill, and X. Z. Su. 2002. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 418:320-323. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES